GOLDMAN MYLA LAI Insider Trading $LH LABORATORY CORP OF AMERICA HOLDINGS
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GOLDMAN MYLA LAI.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GOLDMAN MYLA LAI. GOLDMAN MYLA LAI is EVP & Chief Medical Officer in LABORATORY CORP OF AMERICA HOLDINGS ($LH).
GOLDMAN MYLA LAI in LABORATORY CORP OF AMERICA HOLDINGS
Trading Symbol: LHIndustry: SERVICES-MEDICAL LABORATORIES [8071]
Position of GOLDMAN MYLA LAI: EVP & Chief Medical Officer
Holdings: 22,660 shares
Current Value: $2,942,628
Latest Transaction: May 09 2008
$LH Market Capitalization: $13.45B
$LH Previous Close: $129.86
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of GOLDMAN MYLA LAI in LABORATORY CORP OF AMERICA HOLDINGS
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 22 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.45 | 97 | 5,670 | 43,242 | 43.3 K to 43.2 K (-0.22 %) |
Feb 22 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.46 | 2,238 | 130,833 | 43,339 | 45.6 K to 43.3 K (-4.91 %) |
Feb 22 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.49 | 876 | 51,237 | 45,577 | 46.5 K to 45.6 K (-1.89 %) |
Feb 22 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.50 | 97 | 5,675 | 46,453 | 46.6 K to 46.5 K (-0.21 %) |
Feb 22 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.53 | 32 | 1,873 | 46,550 | 46.6 K to 46.6 K (-0.07 %) |
Feb 22 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.54 | 65 | 3,805 | 46,582 | 46.6 K to 46.6 K (-0.14 %) |
Feb 22 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.55 | 195 | 11,417 | 46,647 | 46.8 K to 46.6 K (-0.42 %) |
Feb 22 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Buy | M | 39.00 | 16,800 | 655,200 | 46,842 | 30 K to 46.8 K (+55.92 %) |
Jan 12 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Option Exercise | M | 39.00 | 16,800 | 655,200 | 33,600 | |
Jan 12 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Option Exercise | M | 39.34 | 20,246 | 796,478 | 0 | |
Jan 12 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 55.00 | 37,046 | 2,037,530 | 30,000 | 67 K to 30 K (-55.25 %) |
Jan 12 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Buy | M | 39.00 | 16,800 | 655,200 | 67,046 | 50.2 K to 67 K (+33.44 %) |
Jan 12 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Buy | M | 39.34 | 20,246 | 796,478 | 50,246 | 30 K to 50.2 K (+67.49 %) |
Jan 11 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Option Exercise | M | 39.34 | 4,398 | 173,017 | 20,246 | |
Jan 11 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 55.00 | 4,398 | 241,890 | 29,959 | 34.4 K to 30 K (-12.80 %) |
Jan 11 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Buy | M | 39.34 | 4,398 | 173,017 | 34,357 | 30 K to 34.4 K (+14.68 %) |
Jan 11 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 54.50 | 2,877 | 156,797 | 29,959 | 32.8 K to 30 K (-8.76 %) |
Jan 11 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 54.51 | 289 | 15,753 | 32,836 | 33.1 K to 32.8 K (-0.87 %) |
Jan 11 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 54.52 | 811 | 44,216 | 33,125 | 33.9 K to 33.1 K (-2.39 %) |
Jan 11 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 54.54 | 58 | 3,163 | 33,936 | 34 K to 33.9 K (-0.17 %) |
Jan 11 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 54.55 | 19 | 1,036 | 33,994 | 34 K to 34 K (-0.06 %) |
Jan 11 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 54.58 | 39 | 2,129 | 34,013 | 34.1 K to 34 K (-0.11 %) |
Jan 11 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 54.59 | 231 | 12,610 | 34,052 | 34.3 K to 34.1 K (-0.67 %) |
Jan 11 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 54.60 | 657 | 35,872 | 34,283 | 34.9 K to 34.3 K (-1.88 %) |
Jan 11 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 54.80 | 77 | 4,220 | 34,940 | 35 K to 34.9 K (-0.22 %) |
Jan 11 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Payment of Exercise | F | 55.00 | 2,535 | 139,425 | 35,017 | 37.6 K to 35 K (-6.75 %) |
Jan 10 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Option Exercise | M | 39.34 | 4,385 | 172,506 | 24,644 | |
Jan 10 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 55.00 | 4,198 | 230,890 | 37,552 | 41.8 K to 37.6 K (-10.06 %) |
Jan 10 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 55.02 | 150 | 8,253 | 41,750 | 41.9 K to 41.8 K (-0.36 %) |
Jan 10 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 55.03 | 37 | 2,036 | 41,900 | 41.9 K to 41.9 K (-0.09 %) |
Jan 10 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Buy | M | 39.34 | 4,385 | 172,506 | 41,937 | 37.6 K to 41.9 K (+11.68 %) |
Jan 09 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Option Exercise | M | 39.34 | 6,371 | 250,635 | 29,029 | |
Jan 09 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 55.00 | 6,371 | 350,405 | 37,552 | 43.9 K to 37.6 K (-14.50 %) |
Jan 09 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Buy | M | 39.34 | 6,371 | 250,635 | 43,923 | 37.6 K to 43.9 K (+16.97 %) |
May 06 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Option Exercise | M | 24.46 | 16,800 | 410,928 | 16,800 | |
May 06 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 50.08 | 1,200 | 60,096 | 37,129 | 38.3 K to 37.1 K (-3.13 %) |
May 06 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 50.10 | 4,100 | 205,410 | 38,329 | 42.4 K to 38.3 K (-9.66 %) |
May 06 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 50.11 | 400 | 20,044 | 42,429 | 42.8 K to 42.4 K (-0.93 %) |
May 06 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 50.13 | 4,300 | 215,559 | 42,829 | 47.1 K to 42.8 K (-9.12 %) |
May 06 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 50.14 | 700 | 35,098 | 47,129 | 47.8 K to 47.1 K (-1.46 %) |
May 06 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 50.21 | 4,900 | 246,029 | 47,829 | 52.7 K to 47.8 K (-9.29 %) |
May 06 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 50.24 | 100 | 5,024 | 52,729 | 52.8 K to 52.7 K (-0.19 %) |
May 06 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 50.25 | 1,100 | 55,275 | 52,829 | 53.9 K to 52.8 K (-2.04 %) |
May 06 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Buy | M | 24.46 | 16,800 | 410,928 | 53,929 | 37.1 K to 53.9 K (+45.25 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 45.70 | 502 | 22,941 | 37,129 | 37.6 K to 37.1 K (-1.33 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 45.72 | 474 | 21,671 | 37,631 | 38.1 K to 37.6 K (-1.24 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 45.73 | 139 | 6,356 | 38,105 | 38.2 K to 38.1 K (-0.36 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 45.77 | 210 | 9,612 | 38,244 | 38.5 K to 38.2 K (-0.55 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 45.78 | 138 | 6,318 | 38,454 | 38.6 K to 38.5 K (-0.36 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 45.80 | 3,458 | 158,376 | 38,592 | 42.1 K to 38.6 K (-8.22 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 45.81 | 488 | 22,355 | 42,050 | 42.5 K to 42.1 K (-1.15 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 45.82 | 279 | 12,784 | 42,538 | 42.8 K to 42.5 K (-0.65 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 45.83 | 42 | 1,925 | 42,817 | 42.9 K to 42.8 K (-0.10 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 45.85 | 724 | 33,195 | 42,859 | 43.6 K to 42.9 K (-1.66 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 45.86 | 167 | 7,659 | 43,583 | 43.8 K to 43.6 K (-0.38 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 45.90 | 696 | 31,946 | 43,750 | 44.4 K to 43.8 K (-1.57 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 45.91 | 84 | 3,856 | 44,446 | 44.5 K to 44.4 K (-0.19 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 45.92 | 56 | 2,572 | 44,530 | 44.6 K to 44.5 K (-0.13 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 45.95 | 404 | 18,564 | 44,586 | 45 K to 44.6 K (-0.90 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 46.00 | 1,073 | 49,358 | 44,990 | 46.1 K to 45 K (-2.33 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 46.01 | 236 | 10,858 | 46,063 | 46.3 K to 46.1 K (-0.51 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 46.02 | 14 | 644 | 46,299 | 46.3 K to 46.3 K (-0.03 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 46.05 | 501 | 23,071 | 46,313 | 46.8 K to 46.3 K (-1.07 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 46.06 | 153 | 7,047 | 46,814 | 47 K to 46.8 K (-0.33 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 46.18 | 488 | 22,536 | 46,967 | 47.5 K to 47 K (-1.03 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 46.20 | 2,548 | 117,718 | 47,455 | 50 K to 47.5 K (-5.10 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 46.21 | 320 | 14,787 | 50,003 | 50.3 K to 50 K (-0.64 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 46.22 | 28 | 1,294 | 50,323 | 50.4 K to 50.3 K (-0.06 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 46.23 | 42 | 1,942 | 50,351 | 50.4 K to 50.4 K (-0.08 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 46.24 | 28 | 1,295 | 50,393 | 50.4 K to 50.4 K (-0.06 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 46.25 | 98 | 4,533 | 50,421 | 50.5 K to 50.4 K (-0.19 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 46.26 | 42 | 1,943 | 50,519 | 50.6 K to 50.5 K (-0.08 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 46.27 | 28 | 1,296 | 50,561 | 50.6 K to 50.6 K (-0.06 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 46.28 | 28 | 1,296 | 50,589 | 50.6 K to 50.6 K (-0.06 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 46.29 | 42 | 1,944 | 50,617 | 50.7 K to 50.6 K (-0.08 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 46.30 | 56 | 2,593 | 50,659 | 50.7 K to 50.7 K (-0.11 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 46.31 | 153 | 7,085 | 50,715 | 50.9 K to 50.7 K (-0.30 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 46.32 | 98 | 4,539 | 50,868 | 51 K to 50.9 K (-0.19 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 46.34 | 56 | 2,595 | 50,966 | 51 K to 51 K (-0.11 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 46.35 | 28 | 1,298 | 51,022 | 51.1 K to 51 K (-0.05 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 46.38 | 28 | 1,299 | 51,050 | 51.1 K to 51.1 K (-0.05 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 46.40 | 167 | 7,749 | 51,078 | 51.2 K to 51.1 K (-0.33 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 46.41 | 70 | 3,249 | 51,245 | 51.3 K to 51.2 K (-0.14 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 46.42 | 14 | 650 | 51,315 | 51.3 K to 51.3 K (-0.03 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 46.43 | 236 | 10,957 | 51,329 | 51.6 K to 51.3 K (-0.46 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Payment of Exercise | F | 46.60 | 8,087 | 376,854 | 51,565 | 59.7 K to 51.6 K (-13.56 %) |
Mar 03 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Option Exercise | A | 47.89 | 30,000 | 1,436,700 | 30,000 | |
Mar 03 2005 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Grant | A | 0.00 | 8,400 | 0 | 59,652 | 51.3 K to 59.7 K (+16.39 %) |
Nov 30 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Option Exercise | M | 33.06 | 54,400 | 1,798,600 | 0 | |
Nov 30 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 48.00 | 54,400 | 2,611,200 | 51,126 | 105.5 K to 51.1 K (-51.55 %) |
Nov 30 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Buy | M | 33.06 | 54,400 | 1,798,600 | 105,526 | 51.1 K to 105.5 K (+106.40 %) |
Nov 24 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Option Exercise | M | 32.50 | 3,000 | 97,500 | 0 | |
Nov 24 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 47.50 | 3,000 | 142,500 | 51,126 | 54.1 K to 51.1 K (-5.54 %) |
Nov 24 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Buy | M | 32.50 | 3,000 | 97,500 | 54,126 | 51.1 K to 54.1 K (+5.87 %) |